For the financial year ended 31st March, 2019,
Lupin's Consolidated sales and Net profits were at Rs.
Lupin the Third: The First (Screenshot / Toho Movie Channel / MANILA BULLETIN)
Additionally,
Lupin will be entitled to receive a double-digit royalty on the sales of the product and will retain commercial rights to the program in India.
Lupin shares were trading 1.17 percent down at Rs 745.55 per scrip on BSE.
This transaction is a milestone in the evolution of the company's specialty business and gives
Lupin a new therapeutic to bring to obstetricians and gynecologists to treat a serious health condition they see frequently in their practices.
Some of
Lupin's recent generic launches include Fayosim Tablets USP (Quartette); Desoximetasone Ointment USP, 0.05% and 0.25% (Topicort); Desoximetasone Cream USP, 0.05% and 0.25% (Topicort LP Emollient Cream (0.05%); Topicort Cream (0.25%); Bupropion Hydrochloride Extended-Release Tablets USP (XL) (Wellbutrin XL); Moxifloxacin Ophthalmic Solution 0.5% (Vigamox); and Quetiapine Fumarate Extended-Release Tablets (Seroquel XR).
They are also evaluated like any other professional working in
Lupin," says Kamal Sharma, their mentor and Vice Chairman.
* Latest news and deals relating to the
Lupin Limited's pipeline products
In a statement, Vinita Gupta, chief executive officer of
Lupin, said, "This is a pivotal acquisition for
Lupin, as it aligns with our goal to expand and deepen our U.S.
LUPIN will acquire Gavis Pharmaceuticals for ` 5,610 crore in what the country's fourth- largest drugmaker by sales claimed on Thursday is largest by a domestic pharma firm in the US.
Woe betide restaurateurs who don't warn diners of the presence of a bit of
lupin in their meal.